A day after it published its latest set of quarterly earnings, an analyst bumped his price target higher. He also maintained his equivalent of a buy recommendation. 10 stocks we like better than ...

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...

SELLAS Life Sciences Group Inc. SLS has surged over 200% over the last six months, with a year-to-date stock jump of around ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

Cassava Sciences has pivoted from failed Alzheimer’s trials to developing simufilam for TSC-related epilepsy, but has yet to start human trials. A 46.98% share price surge followed CEO Richard Barry’s ...